| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.2 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.17 | 0.2 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |